IPO registrations (S-1, F-1) · Registrants
ARVINAS, INC.
- SEC CIK
- 1655759 · filings on EDGAR ↗
- Name on the registration
- ARVINAS HOLDING COMPANY, LLC
- Former names
- ARVINAS INC. (2018–2018); ARVINAS HOLDING COMPANY, LLC (2015–2018)
- Registration
- Form S-1, first filed 2018-08-30, last 2018-09-14; 1 initial registration, 1 amendment
- Outcome
- Final prospectus filed 2018-09-27; declared effective 2018-09-26
- Industry (SIC)
- Pharmaceutical Preparations 2834
- Incorporated in
- DE
- Business address
- 395 WINCHESTER AVE, 5 SCIENCE PARK, New Haven, CT 06511
- EIN
- 47-2566120
- Ticker
- ARVN (Nasdaq)
- EDGAR entity type
- operating
- Insiders and CEO pay
- ARVINAS, INC. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2018-09-14)
- Final price
- $16.00 per share, within the range (424B4 filed 2018-09-27, an initial public offering)
- Shares sold
- 7,500,000
- Gross proceeds
- $120,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol ARVN
- Lead underwriters
- Goldman Sachs; Citigroup; Piper Sandler
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: ARVINAS, INC. Fuzzy (name and state)
- Business registration: ARVINAS, LLC Fuzzy (name and state)
- Federal award recipient: ARVINAS, INC. Fuzzy (name and state)
- Form D issuer: ARVINAS, INC. EXACT (CIK (EXACT))
- SEC filer: ARVINAS HOLDING COMPANY, LLC EXACT (CIK (EXACT))
- Person page: James E Flynn Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther))
- Person page: John D Diekman Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner))
- Person page: John G Houston Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
- Person page: Leslie V Norwalk Jd Fuzzy (officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director))
Filings 7
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2018-08-30 | S-1 | S-1 (registration) | ARVINAS HOLDING COMPANY, LLC | 0001193125-18-262944 ↗ |
| 2018-09-14 | S-1/A | S-1/A (amendment) | ARVINAS HOLDING COMPANY, LLC | 0001193125-18-273347 ↗ |
| 2018-09-26 | S-1MEF | S-1MEF (added securities) | ARVINAS HOLDING COMPANY, LLC | 0001193125-18-284261 ↗ |
| 2018-09-26 | EFFECT | EFFECT (declared effective) | ARVINAS HOLDING COMPANY, LLC | 9999999995-18-002467 ↗ |
| 2018-09-27 | 424B4 | 424B4 (final prospectus) | ARVINAS HOLDING COMPANY, LLC | 0001193125-18-284959 ↗ |
| 2019-10-10 | EFFECT | EFFECT (declared effective) | ARVINAS, INC. | 9999999995-19-002291 ↗ |
| 2019-10-10 | EFFECT | EFFECT (declared effective) | ARVINAS, INC. | 9999999995-19-002292 ↗ |
Prospectus pages read 2
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2018-09-14 | S-1/A | registration statement | $14.00–$16.00 | 6,666,667 | - | Nasdaq ARVN | 4 | primary document; range, shares headline, cover names 4 | document ↗ | |
| 2018-09-27 | 424B4 | final prospectus | $16.00 | 7,500,000 | $120,000,000 | Nasdaq ARVN | 3 | primary document; price sentence, shares headline, proceeds table, cover names 3 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| 5AM Co-Investors III, L.P. | TenPercentOwner | 6 | 2018–2019 | ||
| 5AM Partners III, LLC | TenPercentOwner | 6 | 2018–2019 | ||
| 5AM VENTURES III, L.P. | TenPercentOwner | 6 | 2018–2019 | ||
| BETTIGOLE ROBERT A. | Other; TenPercentOwner | 2 | 2018 | ||
| Canaan IX L.P. | TenPercentOwner | 5 | 2018–2020 | ||
| Canaan Partners IX LLC | TenPercentOwner | 5 | 2018–2020 | ||
| Cassidy Sean A | Officer | Chief Financial Officer | 24 | 2018–2024 | |
| CONNECTICUT INNOVATIONS INC | TenPercentOwner | 1 | 2018 | ||
| Craig M. Crews Family 2013 Trust | TenPercentOwner | 1 | 2018 | ||
| Crew Andrew | Officer | See Remarks | 3 | 2018–2019 | |
| Crews Craig Martin | TenPercentOwner | 2 | 2018 | ||
| Crews Family 2018 Trust | TenPercentOwner | 1 | 2018 | ||
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | TenPercentOwnerOther | 2 | 2018 | ||
| Deerfield Mgmt III, L.P. | TenPercentOwnerOther | 2 | 2018 | ||
| Deerfield Mgmt IV, L.P. | TenPercentOwnerOther | 2 | 2018 | ||
| Deerfield Mgmt L.P. | TenPercentOwnerOther | 2 | 2018 | ||
| Deerfield Private Design Fund III, L.P. | TenPercentOwnerOther | 2 | 2018 | ||
| Deerfield Private Design Fund IV, L.P. | TenPercentOwnerOther | 2 | 2018 | ||
| Deerfield Special Situations Fund, L.P. | TenPercentOwnerOther | 2 | 2018 | ||
| DIEKMAN JOHN D | TenPercentOwner | 6 | 2018–2019 | person page Fuzzy | |
| ELM STREET VENTURE ASSOCIATES, LLC | Other; TenPercentOwner | 2 | 2018 | ||
| ELM STREET VENTURES L P | Other; TenPercentOwner | 2 | 2018 | ||
| Flynn James E | TenPercentOwnerOther | 2 | 2018 | person page Fuzzy | |
| Houston John G | Director; Director,Officer | President and CEO | 24 | 2018–2026 | person page Fuzzy |
| Kennedy Edward Moore Jr. | Director | 13 | 2018–2026 | ||
| Kolchinsky Peter | Other; TenPercentOwner | 2 | 2018 | ||
| Loven Jakob | Director | 4 | 2018–2020 | ||
| Margus Bradley Albert | Director | 11 | 2018–2022 | ||
| Morrison Briggs | Director | 15 | 2018–2026 | ||
| New Leaf Venture Associates III, L.P. | TenPercentOwner | 1 | 2018 | ||
| New Leaf Venture Management III, L.L.C. | TenPercentOwner | 1 | 2018 | ||
| New Leaf Ventures III, L.P. | TenPercentOwner | 1 | 2018 | ||
| ORBIMED ADVISORS LLC | TenPercentOwner | 1 | 2018 | ||
| OrbiMed Capital GP VI LLC | TenPercentOwner | 1 | 2018 | ||
| PARMAR KUSH | Director | 4 | 2018–2019 | ||
| RA Capital Healthcare Fund LP | Other; TenPercentOwner | 2 | 2018 | ||
| RA CAPITAL MANAGEMENT, LLC | Other; TenPercentOwner | 2 | 2018 | ||
| Ratcliffe Liam | Director; Director,TenPercentOwner | 12 | 2018–2022 | ||
| ROCKLAGE SCOTT M | TenPercentOwner | 6 | 2018–2019 | ||
| Schwab Andrew J. | TenPercentOwner | 6 | 2018–2019 | ||
| SHANNON TIMOTHY M | Director | 14 | 2018–2022 | ||
| Taylor Ian | Officer | Chief Scientific Officer; President, R&D; Senior Vice President, Biology | 25 | 2018–2025 | |
| Norwalk Leslie V | Director | 9 | 2019–2026 | person page Fuzzy | |
| Peck Ronald | Officer | Chief Medical Officer | 15 | 2019–2024 | |
| Smaldone Alsup Laurie | Director | 9 | 2019–2026 | ||
| Bain Linda | Director | 8 | 2020–2026 | ||
| DIXON WENDY L | Director | 6 | 2020–2023 | ||
| YOUNG JOHN D | Director | 5 | 2022–2025 | ||
| Cunningham Everett | Director | 6 | 2022–2026 | ||
| Loomis David K | Officer | Chief Accounting Officer; VP, Chief Accounting Officer | 11 | 2022–2026 | |
| AGARWAL SUNIL | Director | 4 | 2023–2025 | ||
| Teel Randy | Director,Officer; Officer | Int. Chief Financial Officer; President and CEO | 9 | 2024–2026 | |
| Berkowitz Noah | Officer | Chief Medical Officer | 9 | 2024–2026 | |
| Cacace Angela M | Officer | Chief Scientific Officer | 11 | 2024–2026 | |
| Saik Andrew | Officer | Chief Financial Officer | 9 | 2024–2026 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Private offerings before or after (Form D)
| First filed | Issuer | Industry | Offering | Sold | Investors | Filings |
|---|---|---|---|---|---|---|
| 2019-07-19 | ARVINAS, INC. | Biotechnology | $32,499,996 | $32,499,996 | 1 | 1 |
| 2018-04-05 | ARVINAS HOLDING COMPANY, LLC | Biotechnology | $55,000,000 | $55,000,000 | 22 | 1 |
| 2015-10-23 | ARVINAS HOLDING COMPANY, LLC | Biotechnology | $41,609,999 | $41,609,999 | 16 | 1 |
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| Form D issuer | ARVINAS, INC. | CT | Form D private offerings | CIK (EXACT) |
| SEC filer | ARVINAS, INC. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | ARVINAS, INC. | State business registries | name and state | |
| Business registration | ARVINAS, LLC | State business registries | name and state | |
| Federal award recipient | ARVINAS, INC. | Federal spending (USAspending) | name and state | |
| Person page | James E Flynn | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwnerOther) | |
| Person page | John D Diekman | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (TenPercentOwner) | |
| Person page | John G Houston | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) | |
| Person page | Leslie V Norwalk Jd | People (Form 990 officers, directors and employees) | officer, director or 10% owner on the company's Forms 3, 4 and 5 (Director) |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Pharmaceutical Preparations, CT first:
- CHIREX INC CT
- ACHILLION PHARMACEUTICALS INC CT
- Rib-X Pharmaceuticals, Inc. CT
- Oracle Healthcare Acquisition Corp. CT
- NANOVIRICIDES, INC. CT
- KOLLTAN PHARMACEUTICALS INC CT
- Trevi Therapeutics, Inc. CT
- Yarrow Bioscience, Inc. CT
- Loxo Oncology, Inc. CT
- Biohaven Pharmaceutical Holding Co Ltd. CT
In other datasets, the same topic (Health) in CT:
- Nonprofit: AIDS BUDDY NETWORK (Nonprofits (IRS Form 990))
Interests: Pharmaceutical Preparations · Health